Cargando…

Patients with disorders of sex development

Disorders of sex development (DSDs) are a genetically and clinically heterogeneous group of congenital conditions of the urogenital tract and reproductive system. Time and spatially controlled transcription factors, signal molecules, and an array of different hormones are involved in the development...

Descripción completa

Detalles Bibliográficos
Autor principal: Markosyan, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Pediatric Endocrinology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255866/
https://www.ncbi.nlm.nih.gov/pubmed/34218628
http://dx.doi.org/10.6065/apem.2040240.120
_version_ 1783717998870134784
author Markosyan, Renata
author_facet Markosyan, Renata
author_sort Markosyan, Renata
collection PubMed
description Disorders of sex development (DSDs) are a genetically and clinically heterogeneous group of congenital conditions of the urogenital tract and reproductive system. Time and spatially controlled transcription factors, signal molecules, and an array of different hormones are involved in the development of sex characteristics, and variations in their pathways and actions are associated with DSD. These conditions may be caused by numerical or structural variations in sex chromosomes as well as autosomes, variations in genes involved in gonadal and/or genital development, and changes in gonadal and/or adrenal steroidogenesis. Endogenous or exogenous (maternal) and possibly endocrine disruptors may also interfere with genital development.
format Online
Article
Text
id pubmed-8255866
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Society of Pediatric Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-82558662021-07-15 Patients with disorders of sex development Markosyan, Renata Ann Pediatr Endocrinol Metab Review Article Disorders of sex development (DSDs) are a genetically and clinically heterogeneous group of congenital conditions of the urogenital tract and reproductive system. Time and spatially controlled transcription factors, signal molecules, and an array of different hormones are involved in the development of sex characteristics, and variations in their pathways and actions are associated with DSD. These conditions may be caused by numerical or structural variations in sex chromosomes as well as autosomes, variations in genes involved in gonadal and/or genital development, and changes in gonadal and/or adrenal steroidogenesis. Endogenous or exogenous (maternal) and possibly endocrine disruptors may also interfere with genital development. Korean Society of Pediatric Endocrinology 2021-06 2021-06-30 /pmc/articles/PMC8255866/ /pubmed/34218628 http://dx.doi.org/10.6065/apem.2040240.120 Text en © 2021 Annals of Pediatric Endocrinology & Metabolism https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Markosyan, Renata
Patients with disorders of sex development
title Patients with disorders of sex development
title_full Patients with disorders of sex development
title_fullStr Patients with disorders of sex development
title_full_unstemmed Patients with disorders of sex development
title_short Patients with disorders of sex development
title_sort patients with disorders of sex development
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255866/
https://www.ncbi.nlm.nih.gov/pubmed/34218628
http://dx.doi.org/10.6065/apem.2040240.120
work_keys_str_mv AT markosyanrenata patientswithdisordersofsexdevelopment